IHAM
CCXI
Integral Health Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-574,029
| Closed | -$14.2M | – | 86 |
|
|
2022
Q2 | $14.2M | Buy |
574,029
+174,029
| +44% | +$4.31M | 2.93% | 9 |
|
|
2022
Q1 | $10M | Buy |
400,000
+200,000
| +100% | +$5.01M | 2.61% | 10 |
|
|
2021
Q4 | $7.28M | Sell |
200,000
-100,000
| -33% | -$3.64M | 2.02% | 18 |
|
|
2021
Q3 | $5.13M | Buy |
300,000
+125,000
| +71% | +$2.14M | 1.47% | 24 |
|
|
2021
Q2 | $2.34M | Buy |
175,000
+20,000
| +13% | +$268K | 0.65% | 46 |
|
|
2021
Q1 | $7.94M | Sell |
155,000
-25,000
| -14% | -$1.28M | 2.27% | 15 |
|
|
2020
Q4 | $11.1M | Sell |
180,000
-5,000
| -3% | -$310K | 3.32% | 7 |
|
|
2020
Q3 | $10.1M | Buy |
185,000
+35,000
| +23% | +$1.92M | 3.1% | 7 |
|
|
2020
Q2 | $8.63M | Sell |
150,000
-40,000
| -21% | -$2.3M | 2.58% | 10 |
|
|
2020
Q1 | $7.63M | Buy |
190,000
+140,000
| +280% | +$5.63M | 3.36% | 9 |
|
|
2019
Q4 | $1.98M | Buy |
+50,000
| New | +$1.98M | 0.77% | 37 |
|